Rose, WE SHARE THE SAME CONCERNS! I was hopeful for a takeover long ago,
as I believed it made solid business sense. Today, AMRN may be at a
crossroad: either AMRN will be acquired within the next few months...
or AMRN will proceed to GIA which will end in disappointment for all,
and less Vascepa for those who need it. If JT and his BOD do not see
what we both we both see then they are blinded by either hubris or
greed. Look at all of the opportunities missed while waiting for
a hoped for buyout. AMRN has been what I would think to be a
most desirable takeout target for BP...even Adam Feuerstein saw that!
Watching the generic Lovaza scrips grow is sickening...JT has failed
here!
Market Data 
Markets 
AI
